Albocycline K3, identified by its CAS number 178114-31-3, is a member of the albocycline family, which are naturally occurring antibiotics derived from certain strains of Streptomyces bacteria. This compound exhibits antibacterial properties, primarily effective against a range of Gram-positive bacteria. Its mechanism of action typically involves inhibition of bacterial protein synthesis, which disrupts cell growth and replication. Albocycline K3 is characterized by its complex molecular structure, which includes multiple rings and functional groups that contribute to its biological activity. The compound is often studied for its potential therapeutic applications, particularly in the treatment of infections caused by resistant bacterial strains. Additionally, research into albocycline K3 may explore its pharmacokinetics, stability, and potential side effects, as well as its efficacy in combination therapies. As with many antibiotics, the development of resistance is a significant concern, necessitating ongoing research to optimize its use in clinical settings.

albocycline K3

178114-31-3: Albocycline K3, identified by its CAS number 178114-31-3, is a member of the albocycline family, which are naturally occurring antibiotics derived from certain strains of Streptomyces bacteria. This compound exhibits antibacterial properties, primarily effective against a range of Gram-positive bacteria. Its mechanism of action typically involves inhibition of bacterial protein synthesis, which disrupts cell growth and replication. Albocycline K3 is characterized by its complex molecular structure, which includes multiple rings and functional groups that contribute to its biological activity. The compound is often studied for its potential therapeutic applications, particularly in the treatment of infections caused by resistant bacterial strains. Additionally, research into albocycline K3 may explore its pharmacokinetics, stability, and potential side effects, as well as its efficacy in combination therapies. As with many antibiotics, the development of resistance is a significant concern, necessitating ongoing research to optimize its use in clinical settings.

<p>Albocycline K3 is an inhibitor of melanogenesis derived from microorganisms.</p>

CAS 178114-31-3

albocycline K3

Albocycline K3

Ref: TM-TN9030